Literature DB >> 86788

Epidemic hepatitis B caused by commercial human immunoglobulin.

T J John, G T Ninan, M S Rajagopalan, F John, T H Flewett, D P Francis, A J Zuckerman.   

Abstract

An epidemic of acute hepatitis B followed the administration of human immunoglobulin to members of the staff of a mission hospital in India and their families. Jaundice developed in 123 (38%) of 325 persons inoculated. Hepatitis-B surface antigen was detected in three of the batches of immunoglobulin which were available for testing.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86788     DOI: 10.1016/s0140-6736(79)92964-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

Review 1.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

2.  Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities.

Authors:  Patricia Volkow; Kimberly C Brouwer; Oralia Loza; Rebeca Ramos; Remedios Lozada; Richard S Garfein; Carlos Magis-Rodriguez; Michelle Firestone-Cruz; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2009-02-20

3.  A prospective controlled crossover trial of a new heat-treated intravenous immunoglobulin.

Authors:  S R Zuhrie; A D Webster; R Davies; A C Fay; T B Wallington
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

Review 4.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.